Clinical trial
Nalbuphine for the Treatment of Opioid Induced Pruritus in Children
NCT00323154 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nalbuphine for the Treatment of Opioid Induced Pruritus in Children
- Lead sponsor
- University of British Columbia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- December 31, 2004
- Enrollment
- 134 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pruritis